GSK Pharma stock gains over 3% after profit, revenue boost in Q2 earnings

Quick Summary:

Shares of GlaxoSmithKline (GSK) Pharmaceuticals surged up to 3.4 per cent at Rs 2719.

The paediatric vaccine portfolio delivered double-digit growth and retained market leadership in the private sector.

In the adult vaccines segment, GSK is enhancing its presence with the Shingrix Herpes Zoster Vaccine, driving growth in adult immunisation through innovative market strategies.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: India

Topics: Sensex GSK Pharma news GSK Pharma share price GSK Pharma GSK Pharma share price Buzzing stocks GSK Pharma shares Stock market GSK Pharma share price today

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-10-30 @ 11:00:36 (2 days ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 407 words

Reading Time: 3 minutes read

Sentences: 20 lines

Sentence Length: 21 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 23335363

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 257 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions